2022 Development Team Review Technical Review 
TechCrunch
OCTOBER 25, 2022
Will your organization and your code pass technical due diligence when it’s your turn? Let’s start with the positives: If an investor is proceeding with technical due diligence (TDD), you’ll likely pass. Here’s the not-so-good news: Companies can pass the business test, but fail TDD.
TechCrunch
FEBRUARY 9, 2023
Last year was a good 12 months of firsts for African tech startups. For the first time, the sector attracted over 1,100 unique investors in 2022, which in turn resulted in a record fundraising haul of $6.5 We are slowly building a more durable capital base for African tech. billion, according to data from Partech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
MARCH 7, 2023
However, it appears that even though VCs are proceeding more cautiously than before and taking their time with due diligence, they are still investing. CB Insights recently found that two of the largest global VC firms, Sequoia Capital and Andreessen Horowitz, actually backed more fintech companies in 2022 than any other category.
TechCrunch
MARCH 18, 2022
” is a staple of Gen X humor, since it reaffirms the cynical viewpoint that technology frequently fails to deliver on its lofty promises. “I’ve been working in the aircraft development space for decades, but 2021 was different,” Tigner writes. “Where’s my flying car?” An emphasis on noise pollution.
TechCrunch
JANUARY 3, 2023
Yuval Krigel is an associate at YL Ventures who focuses on deal sourcing, technological due diligence and providing value-add support to the firm’s portfolio companies. After closing the book on 2022 this week, it is safe to say that this optimism was somewhat misguided. Image Credits: YL Ventures (opens in a new window).
TechCrunch
DECEMBER 15, 2022
. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. We also see AI being used in the biologics space, although the technology is used there far earlier. We are many more above this.
TechCrunch
SEPTEMBER 30, 2022
“Short term, it might be more difficult to raise at valuations we have seen before the public market adjustment, but with a strong business model and an experienced management team that understands the market and growth KPIs, it is possible,” she said. Insurtech IPOs don’t seem to be on the cards for 2022.
Expert insights. Personalized for you.
231 
Let's personalize your content